| Title: | Phenotypic and genetically predicted leucocyte telomere length and lung cancer risk in the prospective UK Biobank |
| Journal: | Thorax |
| Published: | 17 Jan 2024 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/38238005/ |
| DOI: | https://doi.org/10.1136/thorax-2023-220076 |
| URL: | https://thorax.bmj.com/content/thoraxjnl/early/2024/01/17/thorax-2023-220076.full.pdf |
Publication 8927
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
We investigated phenotypic leucocyte telomere length (LTL), genetically predicted LTL (gTL), and lung cancer risk among 371 890 participants, including 2829 incident cases, from the UK Biobank. Using multivariable Cox regression, we found dose-response relationships between longer phenotypic LTL (p-trendcontinuous=2.6×10-5), longer gTL predicted using a polygenic score with 130 genetic instruments (p-trendcontinuous=4.2×10-10), and overall lung cancer risk, particularly for adenocarcinoma. The associations were prominent among never smokers. Mendelian Randomization analyses supported causal associations between longer telomere length and lung cancer (HRper 1 SD gTL=1.87, 95% CI: 1.49 to 2.36, p=4.0×10-7), particularly adenocarcinoma (HRper 1 SD gTL=2.45, 95%CI: 1.69 to 3.57, p=6.5×10-6).</p>
10 Authors
- Jason YY Wong
- Batel Blechter
- Aubrey K Hubbard
- Mitchell J Machiela
- Jianxin Shi
- Shahinaz M Gadalla
- Wei Hu
- Mohammad L Rahman
- Nathaniel Rothman
- Qing Lan
Enabling scientific discoveries that improve human health